MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Blockade of miR-663b inhibits cell proliferation and induces apoptosis in osteosarcoma via regulating TP73 expression	https://doi.org/10.4149/BLL_2018_009	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-340-5p modulates cisplatin resistance by targeting LPAAT? in osteosarcoma	https://doi.org/10.1590/1414-431X20176359	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAAT?/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p	https://doi.org/10.1002/jcb.28244	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway	https://doi.org/10.1016/j.prp.2018.12.013	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells	https://doi.org/10.1371/journal.pone.0079231	2013	Cell line 6 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs).	https://doi.org/10.3390/ijms18122742	2017	Cell line 9 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression	https://doi.org/10.3892/or.2014.3459	2014	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Hsa_circ_0000285 functions as a competitive endogenous RNA to promote osteosarcoma progression by sponging hsa-miRNA-599	https://doi.org/10.1038/s41434-019-0112-5	2019	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21	https://doi.org/10.1002/jcb.26671	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest	https://doi.org/10.1038/srep26611	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Bioinformatics prediction of miR-30a targets and its inhibition of cell proliferation of osteosarcoma by up-regulating the expression of PTEN	https://doi.org/10.1186/s12920-017-0300-3	2017	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-1270 is associated with poor prognosis and its inhibition yielded anticancer mechanisms in human osteosarcoma	https://doi.org/10.1002/iub.1753	2018	Cell line 9 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-192-5p suppresses the initiation and progression of osteosarcoma by targeting USP1	https://doi.org/10.3892/ol.2018.8180	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-23b-3p suppressing PGC1? promotes proliferation through reprogramming metabolism in osteosarcoma	https://doi.org/10.1038/s41419-019-1614-1	2019	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-181a promotes proliferation and inhibits apoptosis by suppressing CFIm25 in osteosarcoma	https://doi.org/10.3892/mmr.2016.5741	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line	https://doi.org/10.1007/s11845-014-1225-x	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
IGF1 3'UTR functions as a ceRNA in promoting angiogenesis by sponging miR-29 family in osteosarcoma	https://doi.org/10.1007/s10735-016-9659-2	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-142 suppresses proliferation and induces apoptosis of osteosarcoma cells by upregulating Rb	https://doi.org/10.3892/ol.2018.8761	2018	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1	https://doi.org/10.3389/fgene.2015.00233	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5	https://doi.org/10.1016/j.biopha.2018.04.193	2018	Cell line 5 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications